These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16226079)

  • 21. [Short QT syndrome].
    Wolpert C; Veltmann C; Schimpf R; Borggrefe M; Herrera-Siklody C; Parade U; Strotmann C; Rüb N
    Herzschrittmacherther Elektrophysiol; 2012 Sep; 23(3):220-4. PubMed ID: 23001291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital short QT syndrome. A review.
    Ginghină C; Ciudin R; Lăpuşanu O; Kulcsar I; Selaru A; Gherasim D
    Rom J Intern Med; 2005; 43(3-4):165-72. PubMed ID: 16812977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
    Schimpf R; Wolpert C; Bianchi F; Giustetto C; Gaita F; Bauersfeld U; Borggrefe M
    J Cardiovasc Electrophysiol; 2003 Dec; 14(12):1273-7. PubMed ID: 14678099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.
    Wolpert C; Schimpf R; Giustetto C; Antzelevitch C; Cordeiro J; Dumaine R; Brugada R; Hong K; Bauersfeld U; Gaita F; Borggrefe M
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):54-8. PubMed ID: 15673388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
    McPate MJ; Duncan RS; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2006 Sep; 41(3):563-6. PubMed ID: 16842817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short QT Syndrome: a familial cause of sudden death.
    Gaita F; Giustetto C; Bianchi F; Wolpert C; Schimpf R; Riccardi R; Grossi S; Richiardi E; Borggrefe M
    Circulation; 2003 Aug; 108(8):965-70. PubMed ID: 12925462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple clinical profiles of families with the short QT syndrome.
    Akdis D; Saguner AM; Medeiros-Domingo A; Schaller A; Balmer C; Steffel J; Brunckhorst C; Duru F
    Europace; 2018 Jun; 20(FI1):f113-f121. PubMed ID: 29016797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of a pediatric cohort with short QT syndrome.
    Villafañe J; Atallah J; Gollob MH; Maury P; Wolpert C; Gebauer R; Watanabe H; Horie M; Anttonen O; Kannankeril P; Faulknier B; Bleiz J; Makiyama T; Shimizu W; Hamilton RM; Young ML
    J Am Coll Cardiol; 2013 Mar; 61(11):1183-91. PubMed ID: 23375927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.
    Hong K; Bjerregaard P; Gussak I; Brugada R
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):394-6. PubMed ID: 15828882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvolt T-wave alternans in short QT syndrome.
    Maury P; Extramiana F; Giustetto C; Cardin C; Rollin A; Duparc A; Mondoly P; Denjoy I; Delay M; Messali A; Leenhardt A; Marangoni D
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1413-9. PubMed ID: 22897428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short QT syndrome: clinical findings and diagnostic-therapeutic implications.
    Giustetto C; Di Monte F; Wolpert C; Borggrefe M; Schimpf R; Sbragia P; Leone G; Maury P; Anttonen O; Haissaguerre M; Gaita F
    Eur Heart J; 2006 Oct; 27(20):2440-7. PubMed ID: 16926178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early repolarisation with ventricular fibrillation in a young woman].
    Ben Ameur Y; Ben Slima H; Joulak A; Sdiri W; Tlili R; Boujnah MR
    Presse Med; 2013 Apr; 42(4 Pt 1):474-9. PubMed ID: 22959338
    [No Abstract]   [Full Text] [Related]  

  • 35. J wave elevation to monitor quinidine efficacy in early repolarization syndrome.
    Sacher F; Derval N; Horlitz M; Haïssaguerre M
    J Electrocardiol; 2014; 47(2):223-5. PubMed ID: 24332747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles.
    Whittaker DG; Ni H; Benson AP; Hancox JC; Zhang H
    Front Physiol; 2017; 8():759. PubMed ID: 29085299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
    Luo C; Wang K; Zhang H
    Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging therapeutic targets in the short QT syndrome.
    Hancox JC; Whittaker DG; Du C; Stuart AG; Zhang H
    Expert Opin Ther Targets; 2018 May; 22(5):439-451. PubMed ID: 29697308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital short QT syndrome.
    Crotti L; Taravelli E; Girardengo G; Schwartz PJ
    Indian Pacing Electrophysiol J; 2010 Feb; 10(2):86-95. PubMed ID: 20126594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long QT syndrome and short QT syndrome.
    Zareba W; Cygankiewicz I
    Prog Cardiovasc Dis; 2008; 51(3):264-78. PubMed ID: 19026859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.